Latest XVIVO News & Updates

See the latest news and media coverage for XVIVO. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
XVIVO

Organ perfusion technologies provider

xvivogroup.com
Headquarters
Mölndal, Sweden
Founded year
1998
Company type
Public company
Number of employees
50–300

Last updated

Latest news about XVIVO

In short: XVIVO reported positive 2026 Q1 financial results, secured expanded heart technology access in France, and achieved successful clinical trial data.

Company announcements

XVIVO

XVIVO holds Annual General Meeting

Resolutions include adopting 2025 financials, no dividend, board re-elections, new incentive program, and share issue authorizations.

XVIVO

XVIVO reports Q1 2026 financial results

Net sales reached SEK 241 million, up 10%. Organic growth was 23% in local currencies. EBIT was SEK 31.9 million. Positive cash flow achieved.

Unlock all announcements with a

Media coverage

Morningstar

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)

The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion AB (publ) ("XVIVO Perfusion" or the "Company") held today on...

Unlock all articles with a

Never miss news about XVIVO

Track XVIVO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.